Blood test to detect liver cancer return after surgery
Part of Cancer, Digestive system clinical trials.
This study looks at whether a blood test (measuring a protein called AKR1B10) can help detect if liver cancer comes back after surgery. It may help doctors monitor patients more closely after tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have hepatocellular carcinoma (the most common type of liver cancer).
- You must be able to have surgery to completely remove the tumor (called a radical resection).
- You must not have received any cancer treatment before this surgery.
- You cannot be pregnant or breastfeeding.
- You cannot have serious heart, brain, lung, kidney, or blood problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test that looks for signs of liver cancer coming back after treatment. It may help doctors find recurrence early and plan better care.
This study tests if a simple urine test can help find early signs of liver cancer coming back after surgery. Patients with early-stage liver cancer who have surgery may join to help improve follow-up care.
This trial studies a new blood test that looks for DNA from cancer cells' mitochondria to see if it can catch liver cancer coming back earlier. The goal is to help doctors find recurrence faster and improve follow-up care.
This study looks at blood tests to see if they can predict how well liver cancer responds to a procedure called TACE. Participation involves giving blood samples and having your normal follow-up scans.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
This study looks at whether a blood test for a protein called AKR1B10 can help give early warning of liver cancer (hepatocellular carcinoma) in people with cirrhosis. If you have cirrhosis or chronic hepatitis and are between 18 and 75 years old, you may be able to join.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.